Notice2026-07916
Commissioner's National Priority Voucher (CNPV) Pilot Program; Public Hearing; Request for Comments; Amendment
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 23, 2026
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA) is announcing an amendment to the notice of the public hearing related to the Commissioner's National Priority Voucher (CNPV) Pilot Program. This meeting was announced in the Federal Register of March 23, 2026. The amendment is being made to reflect a change in the DATES, ADDRESSES, FOR FURTHER INFORMATION CONTACT, and IV. Participating in Public Hearing portions of the document. There are no other changes.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 78 (Thursday, April 23, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 78 (Thursday, April 23, 2026)]
[Notices]
[Page 21822]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-07916]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2026-N-2366]
Commissioner's National Priority Voucher (CNPV) Pilot Program;
Public Hearing; Request for Comments; Amendment
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
amendment to the notice of the public hearing related to the
Commissioner's National Priority Voucher (CNPV) Pilot Program. This
meeting was announced in the Federal Register of March 23, 2026. The
amendment is being made to reflect a change in the DATES, ADDRESSES,
FOR FURTHER INFORMATION CONTACT, and IV. Participating in Public
Hearing portions of the document. There are no other changes.
FOR FURTHER INFORMATION CONTACT: Mallika Mundkur, Deputy Chief Medical
Officer, Office of the Commissioner, Food and Drug Administration,
10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-8800,
<a href="/cdn-cgi/l/email-protection#5e1d100e080e2b3c32373d133b3b2a3730391e383a3f7036362d70393128"><span class="__cf_email__" data-cfemail="acefe2fcfafcd9cec0c5cfe1c9c9d8c5c2cbeccac8cd82c4c4df82cbc3da">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: In the Federal Register of March 23, 2026,
91 FR 13849, FDA announced that a public hearing related to the CNPV
Pilot Program would be held on June 12, 2026. On page 13849, in the
third column, the DATES portion of the document is changed to read as
follows:
<bullet> The public hearing will be held with an in-person and
virtual option (i.e., hybrid) on June 4, 2026, from 1:00 p.m. to 4:00
p.m. Eastern Time. Meeting registration, including requests for
participation in the public hearing, can be found at the following
website: <a href="https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026">https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026</a>. All requests for participation, including
those who wish to present during the public hearing, must be received
by April 24, 2026, through the meeting registration page. Questions
about meeting registration and participation should be sent to
<a href="/cdn-cgi/l/email-protection#c2818c929492b7a0aeaba18fa7a7b6abaca582a4a6a3ecaaaab1eca5adb4"><span class="__cf_email__" data-cfemail="2c6f627c7a7c594e40454f6149495845424b6c4a484d0244445f024b435a">[email protected]</span></a> and include the title of this notice:
``Commissioner's National Priority Voucher (CNPV) Pilot Program; Public
Hearing; Request for Comments'').
On page 13850, in the first column, the second and third paragraphs
of the ADDRESSES portion of the document are changed to read as
follows:
<bullet> Additional details, such as any changes to the time of the
public hearing and registration information, will be posted at <a href="https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026">https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026</a>. The online web conference meeting link can be
accessed at <a href="https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026">https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026</a> on the day of the meeting.
<bullet> All written requests for participation in the pilot
program must be received by April 24, 2026 (email to:
<a href="/cdn-cgi/l/email-protection#6b28253b3d3b1e09070208260e0e1f02050c2b0d0f0a45030318450c041d"><span class="__cf_email__" data-cfemail="2f6c617f797f5a4d43464c624a4a5b4641486f494b4e0147475c01484059">[email protected]</span></a>).
On page 13850, in the third column, the FOR FURTHER INFORMATION
CONTACT portion of the document is changed to read as follows:
<bullet> Mallika Mundkur, Deputy Chief Medical Officer, Office of
the Commissioner, Food and Drug Administration, 10903 New Hampshire
Ave., Silver Spring, MD 20993, 301-796-8800,
<a href="/cdn-cgi/l/email-protection#1d5e534d4b4d687f71747e5078786974737a5d7b797c3375756e337a726b"><span class="__cf_email__" data-cfemail="b1f2ffe1e7e1c4d3ddd8d2fcd4d4c5d8dfd6f1d7d5d09fd9d9c29fd6dec7">[email protected]</span></a>.
On page 13852, in the second column, the IV. Participating in
Public Hearing portion of the SUPPLEMENTARY INFORMATION section is
changed to read as follows:
<bullet> Registration: To register to attend or participate in the
free public hearing, please visit the following website: <a href="https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026">https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026</a>.
<bullet> Written Notice of Participation: All written requests for
participation must be received by April 24, 2026, 11:59 p.m. Eastern
Time (email to: <a href="/cdn-cgi/l/email-protection#f7b4b9a7a1a782959b9e94ba9292839e9990b7919396d99f9f84d9909881"><span class="__cf_email__" data-cfemail="a5e6ebf5f3f5d0c7c9ccc6e8c0c0d1cccbc2e5c3c1c48bcdcdd68bc2cad3">[email protected]</span></a>).
<bullet> Transcripts: A link to the transcript will also be
available on the internet at <a href="https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026">https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06042026</a>.
Grace R. Graham,
Deputy Commissioner for Policy, Legislation, and International Affairs.
[FR Doc. 2026-07916 Filed 4-22-26; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 23, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.